Prostate cancer: BETting on epigenetic therapy.
Sarah
S
Seton-Rogers
D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D018797:Cell Cycle Proteins; D006801:Humans; D008297:Male; D009687:Nuclear Proteins / Q000737:chemistry*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D014157:Transcription Factors / Q000737:chemistry*; D014230:Triazoles / Q000494:pharmacology*; D000092468:Bromodomain Containing Proteins
D001381:Azepines; D018797:Cell Cycle Proteins; D009687:Nuclear Proteins; D014157:Transcription Factors; D014230:Triazoles; C561695:(+)-JQ1 compound; C441289:BRD4 protein, human; D000092468:Bromodomain Containing Proteins